Aureus Asset Management LLC Has $3.66 Million Stake in Danaher Corporation (DHR)
Aureus Asset Management LLC increased its position in Danaher Corporation (NYSE:DHR) by 15.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,204 shares of the conglomerate’s stock after buying an additional 5,802 shares during the period. Aureus Asset Management LLC’s holdings in Danaher Corporation were worth $3,659,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the company. Caisse DE Depot ET Placement DU Quebec boosted its stake in Danaher Corporation by 1.1% in the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,604,313 shares of the conglomerate’s stock valued at $137,366,000 after buying an additional 17,500 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Danaher Corporation by 17.8% in the first quarter. Dimensional Fund Advisors LP now owns 4,661,469 shares of the conglomerate’s stock valued at $398,696,000 after buying an additional 703,224 shares during the last quarter. Geode Capital Management LLC boosted its stake in Danaher Corporation by 6.0% in the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock valued at $496,687,000 after buying an additional 329,458 shares during the last quarter. Bluestein R H & Co. acquired a new stake in Danaher Corporation during the first quarter valued at $214,000. Finally, Cambridge Investment Research Advisors Inc. boosted its stake in Danaher Corporation by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 13,054 shares of the conglomerate’s stock valued at $1,117,000 after buying an additional 840 shares during the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.
Danaher Corporation (NYSE DHR) traded down 0.41% on Tuesday, hitting $81.10. The stock had a trading volume of 309,239 shares. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The company has a market cap of $56.34 billion, a price-to-earnings ratio of 25.89 and a beta of 1.03. The company’s 50 day moving average price is $83.93 and its 200-day moving average price is $84.29.
Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter last year, the business posted $0.90 EPS. Danaher Corporation’s quarterly revenue was up 6.3% compared to the same quarter last year. Equities research analysts anticipate that Danaher Corporation will post $3.95 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Aureus Asset Management LLC Has $3.66 Million Stake in Danaher Corporation (DHR)” was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/08/aureus-asset-management-llc-has-3-66-million-stake-in-danaher-corporation-dhr.html.
Several research firms recently weighed in on DHR. Jefferies Group LLC restated a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday. BidaskClub cut Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 target price for the company in a research note on Friday, July 28th. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Finally, Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $91.76.
In related news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. In the last three months, insiders sold 38,623 shares of company stock worth $3,206,426. Company insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.